India’s Pharma Sector Faces Uncertainty: Deadline for Revised Schedule M Compliance Ends
The clock has run out for pharmaceutical units under ₹250 crore turnover to comply with the revised Schedule M manufacturing […]
The clock has run out for pharmaceutical units under ₹250 crore turnover to comply with the revised Schedule M manufacturing […]
